tiprankstipranks

Carole Ben-Maimon Insider Profile

4 Followers
Carole Ben-Maimon, President, Global Pharm. at Amneal Pharmaceuticals, holds 332.95K shares in Larimar Therapeutics (Ticker: LRMR), holds 16.00K shares in Teligent (Ticker: TLGTQ), holds 85.91K shares in Amneal Pharmaceuticals (Ticker: AMRX).
tipranks
Carole Ben-Maimon

Carole Ben-Maimon
Amneal Pharmaceuticals (AMRX)
President, Global Pharm.

Ranked #25,744 out of 98,564 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+13.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
80.96%
19.04%
A breakdown of Carole Ben-Maimon's holdings

Insider Roles

Larimar Therapeutics
(LRMR)
President & CEO, Director
Amneal Pharmaceuticals
(AMRX)
President, Global Pharm.
Roles that Carole Ben-Maimon holds in companies

Most Profitable Insider Trade

Stock:
Larimar Therapeutics
(LRMR)
Rating:Informative Buy
Date:May 18, 2023 - Today
Return:+73.20%
The most profitable trade made by Carole Ben-Maimon

Carole Ben-Maimon's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amneal Pharmaceuticals
May 16, 2014
President, Global Pharm.
Uninformative Buy
$504.32K
TLGTQ
Teligent
May 31, 2019
Informative Buy
5.80K
$160.00
Larimar Therapeutics
Jan 19, 2024
President & CEO, Director
Uninformative Buy
$2.14M
List of latest transactions for each holding click on a transaction to see Carole Ben-Maimon's performance on stock

Carole Ben-Maimon insider profile FAQ

What is the percentage of profitable transactions made by Carole Ben-Maimon?
The percentage of profitable transactions made by Carole Ben-Maimon is 50%.
    What is the average return per transaction made by Carole Ben-Maimon?
    The average return per transaction made by Carole Ben-Maimon is 13.40%.
      What stocks does Carole Ben-Maimon hold?
      Carole Ben-Maimon holds: AMRX, TLGTQ, LRMR stocks.
        What was Carole Ben-Maimon’s latest transaction?
        Carole Ben-Maimon latest transaction was an Uninformative Buy of ―.
          What was Carole Ben-Maimon's most profitable transaction?
          Carole Ben-Maimon’s most profitable transaction was an Informative Buy of LRMR stock on May 18, 2023. The return on the trade was 73.20%.
            What is Carole Ben-Maimon's role in Amneal Pharmaceuticals?
            Carole Ben-Maimon's role in Amneal Pharmaceuticals is President, Global Pharm..
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.